Business
Certara to Participate in the Stephens Annual Investment Conference
RADNOR, Pa., Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company
About this update from Certara, Inc.
RADNOR, Pa. , Oct. 28, 2024 (GLOBE NEWSWIRE) -- Certara, Inc. (Nasdaq: CERT), a global leader in model-informed drug development, today announced that Company management will participate in the Stephens Annual Investment Conference . Company management will present at 10:00AM CT on Thursday, November 21 st, 2024. A live webcast of the event will be available on Certara’s investor relations website at https://ir.certara.com and will be available for replay for at least 90 days thereafter. About Certara Certara accelerates medicines using biosimulation software, technology, and services to transform traditional drug discovery and development. Its clients include more than 2,400 biopharmaceutical companies, academic institutions, and regulatory agencies across 66 countries. Learn more at certara.com . Investor Relations Contact: David Deuchler Gilmartin Group [email protected] Media Contact: Alyssa Horowitz [email protected] Source: Certara